SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-034443 from AIxCrypto Holdings, Inc. (AIXC)

AIxCrypto Holdings, Inc.
Date: Aug. 29, 2024 · CIK: 0001460702 · Accession: 0001493152-24-034443

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-272623

Date
Aug. 29, 2024
Author
UNIVEST SECURITIES, LLC
Form
CORRESP
Company
AIxCrypto Holdings, Inc.

Letter

Univest Securities, LLC

Rockefeller Plaza 18C

New York, NY 10019

August 29, 2024

VIA EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E. Washington, D.C. 20549

Re: Qualigen Therapeutics, Inc.

Registration Statement on Form S-1, as amended

File No. 333-272623

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement agent, hereby request that the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement on Form S-1 (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on Wednesday, September 4, 2024, or as soon thereafter as practicable.

Pursuant to Rule 460 of the Act, please be advised that there will be distributed to each placement agent or dealer, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
UNIVEST SECURITIES, LLC

Show Raw Text
CORRESP
1
filename1.htm

Univest
Securities, LLC

75
Rockefeller Plaza 18C

New
York, NY 10019

August
29, 2024

VIA
EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.
 Washington, D.C. 20549

 Re: Qualigen
                                            Therapeutics, Inc.

    Registration
                                            Statement on Form S-1, as amended

    File
                                            No. 333-272623

    Request
                                            for Acceleration of Effective Date

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement
agent, hereby request that the Securities and Exchange Commission take appropriate action to cause the above-referenced registration
statement on Form S-1 (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on Wednesday, September
4, 2024, or as soon thereafter as practicable.

Pursuant
to Rule 460 of the Act, please be advised that there will be distributed to each placement agent or dealer, who is reasonably anticipated
to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as
appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The
undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

    Very truly yours,

    UNIVEST SECURITIES, LLC

    By:
    /s/
    Bradley Richmond

    Bradley
    Richmond

    COO
    and Head of Investment Banking

cc: Joseph
                                            Segilia, Esq.

  Sullivan
& Worcester LLP